In 1974, Merck Millipore was the first to market a closed filtration device: Steritest?. Since this time, through dedicated research & development, we have been instrumental in raising the industry?s standards ? reducing the risk of false positive and negative results, increasing reliability and improving workflow for microbiologists around the world.
Merck Millipore celebrates 40 years of first class sterility testing solutions
In 1974, Merck Millipore was the first to market a closed filtration device: Steritest™. Since this time, through dedicated research & development, we have been instrumental in raising the industry's standards – reducing the risk of false positive and negative results, increasing reliability and improving workflow for microbiologists around the world.
We are a one-stop shop that offers an extensive portfolio of quality control products, as well as preventive maintenance, training, validation support and much more.
As we step into the future, Merck Millipore will continue providing reliable high quality products and comprehensive first-class services.
Our latest offer: a rapid sterility testing solution providing results within only 5 days.
40 years is just the beginning
www.merckmillipore.com/40years-steritest
“Conducting a test for sterility requires excellent work flows and a reliable test performance. The Merck Millipore SteritestTM system, with pump and filtration devices, supports the operators in a perfect manner to obtain reliable test results.”
Dr. Timo Krebsbach, Divison Manager Marketing & Sales, Labor L+S AG
Advanced LC-MS Technology for Enhanced HCP Detection in Complex Biotherapeutics
February 26th 2025The identification, characterization, and quantitation of host cell protein (HCP) impurities are a critical challenge in the biopharmaceutical industry. Advanced LC-MS techniques can be integrated into manufacturing workflows to mitigate risks and ensure higher product quality and improved patient safety.